Lumos Signs Pivotal US FebriDx Agreement
Filed with ASX · · 5 pages · English
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings CallLumos Diagnostics Holdings Ltd. on 6ix
In the deck
Earlier from Lumos Diagnostics
- Suspension from Quotation
- Pause in Trading
- Lumos Reaches FebriDx CLIA Waiver Study Enrolment Milestone
- Lumos Reaches Recruitment Milestone in FebriDx Study
- Lumos Secures Sixth US Medicare Reimbursement for FebriDx
Later from Lumos Diagnostics
- Lumos Signs Binding Term Sheet for A$5M Loan Facility
- Lumos Announces FebriDx CLIA Waiver Application Submission
- FY25 Appendix 4E
- LDX & BARDA partner on new US$6.2m FebriDx Paediatric Study
- Lumos secures follow-on PKU contract with Aptatek
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics